Gain the expertise to stand out in your field and collaborate effectively with healthcare professionals
When solutions are reconstituted, they should be made with the right buffers that are listed in the supplier's guidelines
A Phase I/II trial published in the Journal of Clinical Endocrinology & Metabolism (2006) studied CJC-1295 with DAC in healthy adults aged 21-61: Single doses of 30, 60, or 125 g/kg produced dose-dependent increases in GH and IGF-1 Mean GH levels increased 2-10 fold for up to 6 days after a single injection IGF-1 levels increased 1.5-3 fold and remained elevated for 9-11 days After 2-3 weekly doses, steady-state IGF-1 elevation was achieved The most common adverse events were injection site reactions, headache, and diarrhea No serious adverse events were reported in the study timeframe Important Context: ConjuChem's clinical development program for CJC-1295 with DAC was discontinued after a subject death in a subsequent trial
Peptide sellers, since they allegedly are not selling to consumers, do not require a valid prescription and will sell consumers whatever quantity of drug they wish to purchase
McCoin CS, Knotts TA, Adams SH
However, how this happens is not completely understood